Breaking News Instant updates and real-time market news.

VXRT

Vaxart

$4.93 /

-0.27 (-5.19%)

08:06
09/08/20
09/08
08:06
09/08/20
08:06

Vaxart announces pre-publication of manuscript on COVID-19 vaccine candidate

Vaxart announced pre-publication of a manuscript titled "Preclinical studies of a recombinant adenoviral mucosal vaccine to prevent SARS-CoV-2 infection." The manuscript describes the pre-clinical development of a SARS-CoV-2 vaccine based on Vaxart's oral adenovirus platform and is available on an online preprint server. Key Findings: Immunization with the vaccine candidate induced IgA response in the lungs of animals, which is indicative of a mucosal immune response. Of particular note, neutralizing antibodies in the lungs were observed at a very high percentage of the total antibody response. Immunization with our vaccine candidate expressing full length S and N proteins induced IgG responses in a dose-dependent manner. Antigen-specific CD4+ and CD8+ T cells were induced at both low and high doses. Vaccine administration induced only low levels of IL-4 production, suggesting little risk of vaccine- dependent disease enhancement. The study was designed to assess the relative immunogenicity of four candidate vaccines expressing multiple combinations of the spike and nucleocapsid proteins of the SARS-CoV-2 virus in a standard mouse model. While all candidates demonstrated the ability to elicit a strong immune response, the most successful candidate contained the full length S and N proteins. While the S protein is responsible for receptor binding, membrane fusion, and tissue tropism and a major target for neutralizing antibodies, targeting full length S protein in combination with N protein may prevent future vaccine-driven escape due to the accumulation of mutations in the S protein. The inclusion of N protein in the vaccine candidate provides additional conserved T epitopes. Further, the induction of polymeric IgA at mucosal surfaces may be superior for generating neutralizing antibodies against divergent viruses.

VXRT Vaxart
$4.93 /

-0.27 (-5.19%)

08/12/20 H.C. Wainwright
Vaxart price target raised to $17 from $7 at H.C. Wainwright
07/28/20 B. Riley FBR
Vaxart selloff on NY Times article unwarranted, says B. Riley FBR
07/13/20
Fly Intel: Top five analyst initiations
07/13/20 B. Riley FBR
B. Riley FBR starts Vaxart with Buy rating, $22 price target

TODAY'S FREE FLY STORIES

Periodicals
FDA to announce tougher standards for coronavirus vaccine, WaPo says » 15:35
09/22/20
09/22
15:35
09/22/20
15:35
SPY

SPDR S&P 500 ETF Trust

$329.62 /

+2.61 (+0.80%)

, SPX

S&P 500

$0.00 /

+ (+0.00%)

, MRNA

Moderna

$68.96 /

-0.35 (-0.50%)

, JNJ

Johnson & Johnson

$144.60 /

-0.45 (-0.31%)

, MRK

Merck

$83.08 /

-0.03 (-0.04%)

, PFE

Pfizer

$36.17 /

+0.15 (+0.42%)

, NVAX

Novavax

$111.71 /

+1.51 (+1.37%)

, INO

Inovio

$16.93 /

-0.79 (-4.46%)

, AZN

AstraZeneca

$55.51 /

-0.395 (-0.71%)

, BNTX

BioNTech

$67.05 /

+0.9 (+1.36%)

, GSK

GlaxoSmithKline

$38.00 /

-0.205 (-0.54%)

Seeking to to increase…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SPY SPDR S&P 500 ETF Trust
$329.62 /

+2.61 (+0.80%)

SPX S&P 500
$0.00 /

+ (+0.00%)

MRNA Moderna
$68.96 /

-0.35 (-0.50%)

JNJ Johnson & Johnson
$144.60 /

-0.45 (-0.31%)

MRK Merck
$83.08 /

-0.03 (-0.04%)

PFE Pfizer
$36.17 /

+0.15 (+0.42%)

NVAX Novavax
$111.71 /

+1.51 (+1.37%)

INO Inovio
$16.93 /

-0.79 (-4.46%)

AZN AstraZeneca
$55.51 /

-0.395 (-0.71%)

BNTX BioNTech
$67.05 /

+0.9 (+1.36%)

GSK GlaxoSmithKline
$38.00 /

-0.205 (-0.54%)

SPY SPDR S&P 500 ETF Trust
$329.62 /

+2.61 (+0.80%)

09/01/20
Fed's Brainard says monetary policy to pivot from stabilization to accommodation
08/17/20 Goldman Sachs
Goldman boosts end of 2020 S&P 500 target to 3,600 from 3,000
06/04/20 Keefe Bruyette
Mattis rebuke 'wake up call' for stock market, says Keefe Bruyette
03/11/20 Goldman Sachs
Goldman Sachs believes the S&P 500 bull market will soon end
SPX S&P 500
$0.00 /

+ (+0.00%)

09/01/20
Fed's Brainard says monetary policy to pivot from stabilization to accommodation
08/17/20 Goldman Sachs
Goldman boosts end of 2020 S&P 500 target to 3,600 from 3,000
06/04/20 Keefe Bruyette
Mattis rebuke 'wake up call' for stock market, says Keefe Bruyette
03/11/20 Goldman Sachs
Goldman Sachs believes the S&P 500 bull market will soon end
MRNA Moderna
$68.96 /

-0.35 (-0.50%)

09/18/20 Needham
Moderna shares attractive long term on mRNA platform and pipeline, says Needham
09/17/20 Jefferies
Moderna COVID trial stats suggest late Oct. or Nov. for data, says Jefferies
09/09/20 SVB Leerink
AstraZeneca pause 'a mixed blessing for Moderna, others, says SVB Leerink
09/08/20
Fly Intel: Top five analyst downgrades
JNJ Johnson & Johnson
$144.60 /

-0.45 (-0.31%)

09/01/20 Morgan Stanley
Catalent has potential upside from COVID vaccine, says Morgan Stanley
08/25/20 H.C. Wainwright
Momenta downgraded to Neutral from Buy at H.C. Wainwright
08/24/20 Raymond James
Momenta initiated with a Market Perform at Raymond James
08/24/20 Raymond James
Argenx initiated with an Outperform at Raymond James
MRK Merck
$83.08 /

-0.03 (-0.04%)

07:24 Today Stifel
Seattle Genetics price target raised to $165 from $145 at Stifel
09/21/20 Piper Sandler
Regeneron's Libtayo delivered results on par with Keytruda, says Piper Sandler
09/15/20 SVB Leerink
Seattle Genetics price target raised to $185 from $173 at SVB Leerink
09/14/20 RBC Capital
Seattle Genetics price target raised to $191 from $175 at RBC Capital
PFE Pfizer
$36.17 /

+0.15 (+0.42%)

09/21/20 Morgan Stanley
Eli Lilly's Verzenio 'clear winner' over Pfizer's Ibrance, says Morgan Stanley
09/16/20 Baird
uniQure weakness a buying opportunity, says Baird
09/15/20 Citi
Sarepta price target raised to $190 from $177 at Citi
09/09/20 SVB Leerink
AstraZeneca pause 'a mixed blessing for Moderna, others, says SVB Leerink
NVAX Novavax
$111.71 /

+1.51 (+1.37%)

09/15/20 B. Riley FBR
Novavax deal with SIIPL doubles manufacturing capacity, says B. Riley FBR
09/09/20 B. Riley FBR
Astra trial hold opens window for other vaccine candidates, says B. Riley FBR
09/08/20 B. Riley FBR
Novavax selloff brings 'compelling' buying opportunity, says B. Riley FBR
09/03/20 Cantor Fitzgerald
Cantor says Novavax publication in NEJM gives 'validation' for vaccine candidate
INO Inovio
$16.93 /

-0.79 (-4.46%)

09/17/20 Roth Capital
Inovio Covid vaccine has 'virtually no chance,' says Roth Capital
09/09/20 Benchmark
Inovio LOI 'effectively puts to bed' doubts about manufacturing, says Benchmark
08/11/20 Stifel
Inovio price target lowered to $16 from $24 at Stifel
08/11/20 Cantor Fitzgerald
Inovio price target lowered to $31 from $45 at Cantor Fitzgerald
AZN AstraZeneca
$55.51 /

-0.395 (-0.71%)

09/18/20 Societe Generale
Societe Generale ups AstraZeneca target, sees earnings tripling in five years
09/09/20 Piper Sandler
Piper sees 'no readthrough' to Altimmune from AstraZeneca COVID trial hold
09/09/20 SVB Leerink
AstraZeneca pause 'a mixed blessing for Moderna, others, says SVB Leerink
09/09/20 SVB Leerink
AstraZeneca COVID vaccine hold may cause ripple, says SVB Leerink
BNTX BioNTech
$67.05 /

+0.9 (+1.36%)

09/09/20 SVB Leerink
AstraZeneca pause 'a mixed blessing for Moderna, others, says SVB Leerink
09/08/20 B. Riley FBR
Novavax selloff brings 'compelling' buying opportunity, says B. Riley FBR
09/04/20 SVB Leerink
SVB Leerink positive on BioNTech's adding fifth COVID-19 vaccine trial
08/27/20 Chardan
Moderna vaccine showed differentiation from BioNTech/Pfizer's, says Chardan
GSK GlaxoSmithKline
$38.00 /

-0.205 (-0.54%)

09/18/20 Societe Generale
GlaxoSmithKline price target raised to 2,350 GBp at Societe Generale
09/08/20 JPMorgan
GlaxoSmithKline price target lowered to 1,650 GBp from 1,700 GBp at JPMorgan
09/01/20 AlphaValue
GlaxoSmithKline upgraded to Buy from Add at AlphaValue
09/01/20 Morgan Stanley
GlaxoSmithKline price target lowered to 1,700 GBp from 1,725 GBp at Morgan Stanley
SPY SPDR S&P 500 ETF Trust
$329.62 /

+2.61 (+0.80%)

SPX S&P 500
$0.00 /

+ (+0.00%)

MRNA Moderna
$68.96 /

-0.35 (-0.50%)

JNJ Johnson & Johnson
$144.60 /

-0.45 (-0.31%)

MRK Merck
$83.08 /

-0.03 (-0.04%)

PFE Pfizer
$36.17 /

+0.15 (+0.42%)

NVAX Novavax
$111.71 /

+1.51 (+1.37%)

INO Inovio
$16.93 /

-0.79 (-4.46%)

AZN AstraZeneca
$55.51 /

-0.395 (-0.71%)

BNTX BioNTech
$67.05 /

+0.9 (+1.36%)

GSK GlaxoSmithKline
$38.00 /

-0.205 (-0.54%)

  • 23
    Jul
  • 19
    May
  • 12
    Feb
  • 06
    Feb
  • 10
    Oct
SPY SPDR S&P 500 ETF Trust
$329.62 /

+2.61 (+0.80%)

SPX S&P 500
$0.00 /

+ (+0.00%)

MRNA Moderna
$68.96 /

-0.35 (-0.50%)

JNJ Johnson & Johnson
$144.60 /

-0.45 (-0.31%)

MRK Merck
$83.08 /

-0.03 (-0.04%)

PFE Pfizer
$36.17 /

+0.15 (+0.42%)

NVAX Novavax
$111.71 /

+1.51 (+1.37%)

INO Inovio
$16.93 /

-0.79 (-4.46%)

AZN AstraZeneca
$55.51 /

-0.395 (-0.71%)

BNTX BioNTech
$67.05 /

+0.9 (+1.36%)

GSK GlaxoSmithKline
$38.00 /

-0.205 (-0.54%)

MRNA Moderna
$68.96 /

-0.35 (-0.50%)

JNJ Johnson & Johnson
$144.60 /

-0.45 (-0.31%)

MRK Merck
$83.08 /

-0.03 (-0.04%)

PFE Pfizer
$36.17 /

+0.15 (+0.42%)

NVAX Novavax
$111.71 /

+1.51 (+1.37%)

INO Inovio
$16.93 /

-0.79 (-4.46%)

AZN AstraZeneca
$55.51 /

-0.395 (-0.71%)

BNTX BioNTech
$67.05 /

+0.9 (+1.36%)

GSK GlaxoSmithKline
$38.00 /

-0.205 (-0.54%)

SPY SPDR S&P 500 ETF Trust
$329.62 /

+2.61 (+0.80%)

SPX S&P 500
$0.00 /

+ (+0.00%)

MRNA Moderna
$68.96 /

-0.35 (-0.50%)

JNJ Johnson & Johnson
$144.60 /

-0.45 (-0.31%)

MRK Merck
$83.08 /

-0.03 (-0.04%)

PFE Pfizer
$36.17 /

+0.15 (+0.42%)

NVAX Novavax
$111.71 /

+1.51 (+1.37%)

INO Inovio
$16.93 /

-0.79 (-4.46%)

AZN AstraZeneca
$55.51 /

-0.395 (-0.71%)

BNTX BioNTech
$67.05 /

+0.9 (+1.36%)

GSK GlaxoSmithKline
$38.00 /

-0.205 (-0.54%)

SPY SPDR S&P 500 ETF Trust
$329.62 /

+2.61 (+0.80%)

SPX S&P 500
$0.00 /

+ (+0.00%)

Periodicals
Barstool Sportsbook app has record downloads in first weekend, Bloomberg reports » 15:34
09/22/20
09/22
15:34
09/22/20
15:34
PENN

Penn National

$74.33 /

+4.17 (+5.94%)

, DKNG

DraftKings

$53.59 /

+2.11 (+4.10%)

, PDYPY

Flutter Entertainment

$0.00 /

+ (+0.00%)

Penn National (PENN)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PENN Penn National
$74.33 /

+4.17 (+5.94%)

DKNG DraftKings
$53.59 /

+2.11 (+4.10%)

PDYPY Flutter Entertainment
$0.00 /

+ (+0.00%)

PENN Penn National
$74.33 /

+4.17 (+5.94%)

09/17/20 Stifel
Penn National price target raised to $85 from $47 at Stifel
09/15/20 Oppenheimer
DraftKings price target raised to $55 from $50 at Oppenheimer
09/14/20 Goldman Sachs
Penn National price target raised to $66 from $60 at Goldman Sachs
09/14/20 Goldman Sachs
MGM Resorts downgraded to Sell from Neutral at Goldman Sachs
DKNG DraftKings
$53.59 /

+2.11 (+4.10%)

09/15/20 Craig-Hallum
DraftKings price target raised to $60 from $48 at Craig-Hallum
09/15/20 Benchmark
DraftKings price target raised to $57 from $45 at Benchmark
09/15/20 Oppenheimer
DraftKings price target raised to $55 from $50 at Oppenheimer
09/14/20 Jefferies
ESPN deal positive for both Caesars and DraftKings, says Jefferies
PDYPY Flutter Entertainment
$0.00 /

+ (+0.00%)

09/15/20 Oppenheimer
DraftKings price target raised to $55 from $50 at Oppenheimer
09/14/20 Deutsche Bank
Flutter price target raised to 11,800 GBp from 10,200 GBp at Deutsche Bank
09/08/20 Barclays
Flutter Entertainment upgraded to Overweight from Equal Weight at Barclays
09/02/20 Morgan Stanley
Flutter price target raised to 11,500 GBp from 11,000 GBp at Morgan Stanley
PENN Penn National
$74.33 /

+4.17 (+5.94%)

DKNG DraftKings
$53.59 /

+2.11 (+4.10%)

  • 19
    Jun
  • 12
    May
PENN Penn National
$74.33 /

+4.17 (+5.94%)

DKNG DraftKings
$53.59 /

+2.11 (+4.10%)

PDYPY Flutter Entertainment
$0.00 /

+ (+0.00%)

PENN Penn National
$74.33 /

+4.17 (+5.94%)

DKNG DraftKings
$53.59 /

+2.11 (+4.10%)

PENN Penn National
$74.33 /

+4.17 (+5.94%)

DKNG DraftKings
$53.59 /

+2.11 (+4.10%)

Options
KB Home options imply 5.1% move in share price post-earnings » 15:34
09/22/20
09/22
15:34
09/22/20
15:34
KBH

KB Home

$40.63 /

+1.73 (+4.45%)

Pre-earnings options…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KBH KB Home
$40.63 /

+1.73 (+4.45%)

KBH KB Home
$40.63 /

+1.73 (+4.45%)

09/17/20 Barclays
KB Home price target raised to $42 from $39 at Barclays
09/16/20
Fly Intel: Top five analyst upgrades
09/16/20 Evercore ISI
KB Home upgraded to Outperform from In Line at Evercore ISI
08/13/20 Seaport Global
KB Home downgraded to Neutral on construction cost concerns at Seaport Global
KBH KB Home
$40.63 /

+1.73 (+4.45%)

KBH KB Home
$40.63 /

+1.73 (+4.45%)

KBH KB Home
$40.63 /

+1.73 (+4.45%)

Options
Sorrento Therapeutics call volume above normal and directionally bullish » 15:25
09/22/20
09/22
15:25
09/22/20
15:25
SRNE

Sorrento Therapeutics

$10.54 /

+0.78 (+7.99%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SRNE Sorrento Therapeutics
$10.54 /

+0.78 (+7.99%)

SRNE Sorrento Therapeutics
$10.54 /

+0.78 (+7.99%)

07/31/20 H.C. Wainwright
Sorrento Therapeutics price target raised to $30 from $24 at H.C. Wainwright
07/20/20 Dawson James
Sorrento antibody cocktail effort could move quickly, says Dawson James
05/26/20 Dawson James
Sorrento Therapeutics initiated with a Buy at Dawson James
10/07/19 JMP Securities
Sorrento Therapeutics initiated with an Outperform at JMP Securities
SRNE Sorrento Therapeutics
$10.54 /

+0.78 (+7.99%)

SRNE Sorrento Therapeutics
$10.54 /

+0.78 (+7.99%)

SRNE Sorrento Therapeutics
$10.54 /

+0.78 (+7.99%)

Options
Stitch Fix options imply 24.2% move in share price post-earnings » 15:19
09/22/20
09/22
15:19
09/22/20
15:19
SFIX

Stitch Fix

$31.00 /

+1.96 (+6.75%)

Pre-earnings options…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SFIX Stitch Fix
$31.00 /

+1.96 (+6.75%)

SFIX Stitch Fix
$31.00 /

+1.96 (+6.75%)

09/21/20 JPMorgan
Stitch Fix price target raised to $28 from $23 at JPMorgan
09/21/20 Baird
Stitch Fix needs positive forward guidance to propel share higher, says Baird
09/17/20
Fly Intel: Top five analyst initiations
09/17/20
Fly Intel: Top five analyst upgrades
SFIX Stitch Fix
$31.00 /

+1.96 (+6.75%)

SFIX Stitch Fix
$31.00 /

+1.96 (+6.75%)

SFIX Stitch Fix
$31.00 /

+1.96 (+6.75%)

SFIX Stitch Fix
$31.00 /

+1.96 (+6.75%)

Technical Analysis
NASDAQ market internals summary » 15:17
09/22/20
09/22
15:17
09/22/20
15:17
$NSD

NASDAQ Market Internals

$0.00 /

+ (+0.00%)

Volume is above average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
$NSD NASDAQ Market Internals
$0.00 /

+ (+0.00%)

Technical Analysis
NYSE market internals summary » 15:16
09/22/20
09/22
15:16
09/22/20
15:16
$NYE

NYSE Market Internals

$0.00 /

+ (+0.00%)

Volume is average for…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$NYE NYSE Market Internals
$0.00 /

+ (+0.00%)

Hot Stocks
Facebook takes down networks originating in China, Philippines » 15:12
09/22/20
09/22
15:12
09/22/20
15:12
FB

Facebook

$252.89 /

+4.8 (+1.93%)

Facebook said in a blog…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FB Facebook
$252.89 /

+4.8 (+1.93%)

FB Facebook
$252.89 /

+4.8 (+1.93%)

07:38 Today Oppenheimer
Facebook price target raised to $300 from $270 at Oppenheimer
09/18/20 Morgan Stanley
Facebook price target raised to $295 from $285 at Morgan Stanley
09/15/20
Fly Intel: Top five analyst initiations
09/14/20 KeyBanc
Facebook initiated with an Overweight at KeyBanc
FB Facebook
$252.89 /

+4.8 (+1.93%)

FB Facebook
$252.89 /

+4.8 (+1.93%)

FB Facebook
$252.89 /

+4.8 (+1.93%)

FB Facebook
$252.89 /

+4.8 (+1.93%)

Hot Stocks
Notre Dame football game postponed after seven positive COVID tests » 15:11
09/22/20
09/22
15:11
09/22/20
15:11
BYD

Boyd Gaming

$28.52 /

+1.25 (+4.58%)

, MGM

MGM Resorts

$21.54 /

+0.45 (+2.13%)

, CZR

Caesars

$58.31 /

+3.8 (+6.97%)

, CHDN

Churchill Downs

$161.99 /

+7.66 (+4.96%)

, PENN

Penn National

$74.45 /

+4.29 (+6.11%)

, WYNN

Wynn Resorts

$72.96 /

+0.68 (+0.94%)

, LVS

Las Vegas Sands

$46.15 /

-0.28 (-0.60%)

, GAN

Gan Limited

$16.58 /

+ (+0.00%)

, PDYPY

Flutter Entertainment

$0.00 /

+ (+0.00%)

, WIMHY

William Hill

$0.00 /

+ (+0.00%)

, DKNG

DraftKings

$53.76 /

+2.28 (+4.43%)

A total of 94 COVID-19…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BYD Boyd Gaming
$28.52 /

+1.25 (+4.58%)

MGM MGM Resorts
$21.54 /

+0.45 (+2.13%)

CZR Caesars
$58.31 /

+3.8 (+6.97%)

CHDN Churchill Downs
$161.99 /

+7.66 (+4.96%)

PENN Penn National
$74.45 /

+4.29 (+6.11%)

WYNN Wynn Resorts
$72.96 /

+0.68 (+0.94%)

LVS Las Vegas Sands
$46.15 /

-0.28 (-0.60%)

GAN Gan Limited
$16.58 /

+ (+0.00%)

PDYPY Flutter Entertainment
$0.00 /

+ (+0.00%)

WIMHY William Hill
$0.00 /

+ (+0.00%)

DKNG DraftKings
$53.76 /

+2.28 (+4.43%)

BYD Boyd Gaming
$28.52 /

+1.25 (+4.58%)

09/09/20 JPMorgan
Boyd Gaming price target raised to $40 from $30 at JPMorgan
08/28/20 Union Gaming
Boyd Gaming upgraded to Buy from Hold at Union Gaming
07/29/20 JPMorgan
Boyd Gaming price target raised to $30 from $24 at JPMorgan
07/29/20 Deutsche Bank
Boyd Gaming price target raised to $27 from $22 at Deutsche Bank
MGM MGM Resorts
$21.54 /

+0.45 (+2.13%)

09/16/20
Fly Intel: Top five analyst downgrades
09/16/20 Roth Capital
MGM Resorts downgraded to Neutral from Buy at Roth Capital
09/14/20
Fly Intel: Top five analyst downgrades
09/14/20 Goldman Sachs
MGM Resorts downgraded to Sell from Neutral at Goldman Sachs
CZR Caesars
$58.31 /

+3.8 (+6.97%)

11:12 Today Roth Capital
Caesars value creation of $38/share through spinoff likely this year, says Roth
06:42 Today Deutsche Bank
Caesars price target raised to $65 from $50 at Deutsche Bank
09/14/20 Jefferies
ESPN deal positive for both Caesars and DraftKings, says Jefferies
09/14/20 Evercore ISI
ESPN deal could add up to material dollars for DraftKings, says Evercore
CHDN Churchill Downs
$161.99 /

+7.66 (+4.96%)

09/10/20
Fly Intel: Top five analyst downgrades
09/10/20 Jefferies
Jefferies cuts Churchill Downs to Hold after outperformance, ups target to $191
09/10/20 Jefferies
Churchill Downs downgraded to Hold from Buy at Jefferies
08/24/20 Susquehanna
Churchill Downs downgraded to Neutral from Positive at Susquehanna
PENN Penn National
$74.45 /

+4.29 (+6.11%)

09/17/20 Stifel
Penn National price target raised to $85 from $47 at Stifel
09/15/20 Oppenheimer
DraftKings price target raised to $55 from $50 at Oppenheimer
09/14/20 Goldman Sachs
Penn National price target raised to $66 from $60 at Goldman Sachs
09/14/20 Goldman Sachs
MGM Resorts downgraded to Sell from Neutral at Goldman Sachs
WYNN Wynn Resorts
$72.96 /

+0.68 (+0.94%)

09/16/20 Roth Capital
Wynn Resorts downgraded to Neutral from Buy at Roth Capital
09/10/20 Deutsche Bank
Wynn Resorts price target raised to $97 from $89 at Deutsche Bank
09/09/20 JPMorgan
Wynn Resorts price target raised to $101 from $98 at JPMorgan
09/06/20 Goldman Sachs
Wynn Resorts downgraded to Neutral from Conviction Buy at Goldman Sachs
LVS Las Vegas Sands
$46.15 /

-0.28 (-0.60%)

09/16/20
Fly Intel: Top five analyst downgrades
09/16/20 Roth Capital
Las Vegas Sands downgraded to Neutral from Buy at Roth Capital
09/16/20 Roth Capital
Wynn Resorts downgraded to Neutral from Buy at Roth Capital
09/10/20 Deutsche Bank
Las Vegas Sands price target raised to $60 from $54 at Deutsche Bank
GAN Gan Limited
$16.58 /

+ (+0.00%)

08/21/20 B. Riley FBR
Gan selloff on FanDuel loss an overreaction, says B. Riley FBR
08/21/20 Craig-Hallum
Craig-Hallum says FanDuel migration a 'temporary blip' for Gan Limited
08/17/20 B. Riley FBR
DraftKings iGaming results positive for Gan Limited, says B. Riley FBR
08/12/20 Craig-Hallum
NJ sports betting up, iGaming revenue still strong, says Craig-Hallum
PDYPY Flutter Entertainment
$0.00 /

+ (+0.00%)

09/15/20 Oppenheimer
DraftKings price target raised to $55 from $50 at Oppenheimer
09/14/20 Deutsche Bank
Flutter price target raised to 11,800 GBp from 10,200 GBp at Deutsche Bank
09/08/20 Barclays
Flutter Entertainment upgraded to Overweight from Equal Weight at Barclays
09/02/20 Morgan Stanley
Flutter price target raised to 11,500 GBp from 11,000 GBp at Morgan Stanley
WIMHY William Hill
$0.00 /

+ (+0.00%)

09/14/20 Jefferies
William Hill shares haven't priced in building U.S. momentum, says Jefferies
09/10/20 Berenberg
William Hill price target raised to 200 GBp from 150 GBp at Berenberg
09/09/20 Morgan Stanley
William Hill price target raised to 230 GBp from 200 GBp at Morgan Stanley
09/08/20 Barclays
William Hill price target raised to 240 GBp from 200 GBp at Barclays
DKNG DraftKings
$53.76 /

+2.28 (+4.43%)

09/15/20 Craig-Hallum
DraftKings price target raised to $60 from $48 at Craig-Hallum
09/15/20 Benchmark
DraftKings price target raised to $57 from $45 at Benchmark
09/15/20 Oppenheimer
DraftKings price target raised to $55 from $50 at Oppenheimer
09/14/20 Jefferies
ESPN deal positive for both Caesars and DraftKings, says Jefferies
BYD Boyd Gaming
$28.52 /

+1.25 (+4.58%)

MGM MGM Resorts
$21.54 /

+0.45 (+2.13%)

CZR Caesars
$58.31 /

+3.8 (+6.97%)

CHDN Churchill Downs
$161.99 /

+7.66 (+4.96%)

PENN Penn National
$74.45 /

+4.29 (+6.11%)

WYNN Wynn Resorts
$72.96 /

+0.68 (+0.94%)

LVS Las Vegas Sands
$46.15 /

-0.28 (-0.60%)

GAN Gan Limited
$16.58 /

+ (+0.00%)

DKNG DraftKings
$53.76 /

+2.28 (+4.43%)

  • 19
    Jun
  • 12
    May
  • 05
    May
BYD Boyd Gaming
$28.52 /

+1.25 (+4.58%)

MGM MGM Resorts
$21.54 /

+0.45 (+2.13%)

CZR Caesars
$58.31 /

+3.8 (+6.97%)

CHDN Churchill Downs
$161.99 /

+7.66 (+4.96%)

PENN Penn National
$74.45 /

+4.29 (+6.11%)

WYNN Wynn Resorts
$72.96 /

+0.68 (+0.94%)

LVS Las Vegas Sands
$46.15 /

-0.28 (-0.60%)

GAN Gan Limited
$16.58 /

+ (+0.00%)

PDYPY Flutter Entertainment
$0.00 /

+ (+0.00%)

WIMHY William Hill
$0.00 /

+ (+0.00%)

DKNG DraftKings
$53.76 /

+2.28 (+4.43%)

BYD Boyd Gaming
$28.52 /

+1.25 (+4.58%)

MGM MGM Resorts
$21.54 /

+0.45 (+2.13%)

CZR Caesars
$58.31 /

+3.8 (+6.97%)

PENN Penn National
$74.45 /

+4.29 (+6.11%)

WYNN Wynn Resorts
$72.96 /

+0.68 (+0.94%)

LVS Las Vegas Sands
$46.15 /

-0.28 (-0.60%)

GAN Gan Limited
$16.58 /

+ (+0.00%)

DKNG DraftKings
$53.76 /

+2.28 (+4.43%)

BYD Boyd Gaming
$28.52 /

+1.25 (+4.58%)

MGM MGM Resorts
$21.54 /

+0.45 (+2.13%)

CZR Caesars
$58.31 /

+3.8 (+6.97%)

PENN Penn National
$74.45 /

+4.29 (+6.11%)

WYNN Wynn Resorts
$72.96 /

+0.68 (+0.94%)

LVS Las Vegas Sands
$46.15 /

-0.28 (-0.60%)

GAN Gan Limited
$16.58 /

+ (+0.00%)

DKNG DraftKings
$53.76 /

+2.28 (+4.43%)

Hot Stocks
Analog Devices teams with Microsoft to mass produce 3D imaging products » 15:05
09/22/20
09/22
15:05
09/22/20
15:05
ADI

Analog Devices

$114.27 /

+0.36 (+0.32%)

, MSFT

Microsoft

$205.59 /

+2.92 (+1.44%)

Analog Devices (ADI)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ADI Analog Devices
$114.27 /

+0.36 (+0.32%)

MSFT Microsoft
$205.59 /

+2.92 (+1.44%)

ADI Analog Devices
$114.27 /

+0.36 (+0.32%)

08/24/20 Citi
Analog Devices price target raised to $134 from $120 at Citi
08/20/20 Baird
Analog Devices should be owned as a defensive play, says Baird
08/20/20 RBC Capital
Analog Devices price target raised to $135 from $130 at RBC Capital
08/20/20 Goldman Sachs
Analog Devices price target raised to $150 from $142 at Goldman Sachs
MSFT Microsoft
$205.59 /

+2.92 (+1.44%)

09:25 Today Jefferies
Microsoft deal for Bethesda underscores value of high-quality IP, says Jefferies
07:58 Today Credit Suisse
Microsoft's ZeniMax deal fortifies subscription strategy, says Credit Suisse
06:58 Today Deutsche Bank
Deutsche Bank likes Microsoft acquisition of ZeniMax Media
09/21/20 Jefferies
Microsoft 'doubling down on gaming' with deal, says Jefferies
ADI Analog Devices
$114.27 /

+0.36 (+0.32%)

MSFT Microsoft
$205.59 /

+2.92 (+1.44%)

ADI Analog Devices
$114.27 /

+0.36 (+0.32%)

MSFT Microsoft
$205.59 /

+2.92 (+1.44%)

ADI Analog Devices
$114.27 /

+0.36 (+0.32%)

MSFT Microsoft
$205.59 /

+2.92 (+1.44%)

ADI Analog Devices
$114.27 /

+0.36 (+0.32%)

MSFT Microsoft
$205.59 /

+2.92 (+1.44%)

MSFT Microsoft
$205.59 /

+2.92 (+1.44%)

Hot Stocks
UC announces selection for trial of Aerpio COVID-19 drug candidate » 15:05
09/22/20
09/22
15:05
09/22/20
15:05
ARPO

Aerpio Pharmaceuticals

$1.47 /

-0.06 (-3.92%)

Researchers at the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ARPO Aerpio Pharmaceuticals
$1.47 /

-0.06 (-3.92%)

ARPO Aerpio Pharmaceuticals
$1.47 /

-0.06 (-3.92%)

06/25/20 H.C. Wainwright
Aerpio Pharmaceuticals price target raised to $1.50 from $1 at H.C. Wainwright
ARPO Aerpio Pharmaceuticals
$1.47 /

-0.06 (-3.92%)

ARPO Aerpio Pharmaceuticals
$1.47 /

-0.06 (-3.92%)

Options
Aurora Cannabis options imply 35.3% move in share price post-earnings » 15:04
09/22/20
09/22
15:04
09/22/20
15:04
ACB

Aurora Cannabis

$7.18 /

+0.85 (+13.43%)

Pre-earnings options…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ACB Aurora Cannabis
$7.18 /

+0.85 (+13.43%)

ACB Aurora Cannabis
$7.18 /

+0.85 (+13.43%)

07:24 Today Canaccord
Aurora Cannabis price target lowered to C$10 from C$21 at Canaccord
09/21/20 Jefferies
Jefferies upgrades Aurora Cannabis to Hold, cuts price target to C$8.70
09/21/20 Jefferies
Aurora Cannabis upgraded to Hold from Underperform at Jefferies
09/09/20 Stifel
Aurora Cannabis price target lowered to C$10.50 from C$16 at Stifel
ACB Aurora Cannabis
$7.18 /

+0.85 (+13.43%)

ACB Aurora Cannabis
$7.18 /

+0.85 (+13.43%)

ACB Aurora Cannabis
$7.18 /

+0.85 (+13.43%)

ACB Aurora Cannabis
$7.18 /

+0.85 (+13.43%)

Hot Stocks
PagerDuty announces extended integration with Microsoft Teams » 15:02
09/22/20
09/22
15:02
09/22/20
15:02
PD

PagerDuty

$26.85 /

+0.035 (+0.13%)

, MSFT

Microsoft

$205.83 /

+3.16 (+1.56%)

PagerDuty (PD) announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PD PagerDuty
$26.85 /

+0.035 (+0.13%)

MSFT Microsoft
$205.83 /

+3.16 (+1.56%)

PD PagerDuty
$26.85 /

+0.035 (+0.13%)

07/20/20 Monness Crespi
PagerDuty initiated with a Buy at Monness Crespi
06/05/20 JPMorgan
PagerDuty price target raised to $32 from $29 at JPMorgan
06/05/20 RBC Capital
PagerDuty price target raised to $34 from $30 at RBC Capital
05/28/20 RBC Capital
PagerDuty price target raised to $30 from $22 at RBC Capital
MSFT Microsoft
$205.83 /

+3.16 (+1.56%)

09:25 Today Jefferies
Microsoft deal for Bethesda underscores value of high-quality IP, says Jefferies
07:58 Today Credit Suisse
Microsoft's ZeniMax deal fortifies subscription strategy, says Credit Suisse
06:58 Today Deutsche Bank
Deutsche Bank likes Microsoft acquisition of ZeniMax Media
09/21/20 Jefferies
Microsoft 'doubling down on gaming' with deal, says Jefferies
PD PagerDuty
$26.85 /

+0.035 (+0.13%)

MSFT Microsoft
$205.83 /

+3.16 (+1.56%)

MSFT Microsoft
$205.83 /

+3.16 (+1.56%)

PD PagerDuty
$26.85 /

+0.035 (+0.13%)

MSFT Microsoft
$205.83 /

+3.16 (+1.56%)

PD PagerDuty
$26.85 /

+0.035 (+0.13%)

MSFT Microsoft
$205.83 /

+3.16 (+1.56%)

MSFT Microsoft
$205.83 /

+3.16 (+1.56%)

Hot Stocks
Nikola founder Milton appears to have deleted Twitter account » 14:58
09/22/20
09/22
14:58
09/22/20
14:58
NKLA

Nikola

$28.69 /

+1.18 (+4.29%)

When visiting the page…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NKLA Nikola
$28.69 /

+1.18 (+4.29%)

NKLA Nikola
$28.69 /

+1.18 (+4.29%)

09/21/20 Deutsche Bank
Deutsche cuts Nikola target to $29 from $50 after possible 'clearing event'
09/21/20 Cowen
Nikola weakness after executive chair's exit a buying opportunity, says Cowen
09/21/20 RBC Capital
Nikola price target lowered to $21 from $49 at RBC Capital
09/21/20 JPMorgan
JPMorgan cuts Nikola target on elevated risk after Milton resignation
NKLA Nikola
$28.69 /

+1.18 (+4.29%)

NKLA Nikola
$28.69 /

+1.18 (+4.29%)

NKLA Nikola
$28.69 /

+1.18 (+4.29%)

NKLA Nikola
$28.69 /

+1.18 (+4.29%)

Hot Stocks
Applied's phosphomannomutase 2 deficiency treatment granted orphan status » 14:55
09/22/20
09/22
14:55
09/22/20
14:55
APLT

Applied Therapeutics

$22.51 /

-0.02 (-0.09%)

Applied…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
APLT Applied Therapeutics
$22.51 /

-0.02 (-0.09%)

APLT Applied Therapeutics
$22.51 /

-0.02 (-0.09%)

04/22/20
Fly Intel: Top five analyst initiations
04/22/20 Goldman Sachs
Applied Therapeutics initiated with a Buy at Goldman Sachs
02/27/20 Barclays
Applied Therapeutics initiated with an Overweight at Barclays
02/27/20 Barclays
Applied Therapeutics initiated with an Overweight at Barclays
APLT Applied Therapeutics
$22.51 /

-0.02 (-0.09%)

  • 24
    Jan
APLT Applied Therapeutics
$22.51 /

-0.02 (-0.09%)

APLT Applied Therapeutics
$22.51 /

-0.02 (-0.09%)

APLT Applied Therapeutics
$22.51 /

-0.02 (-0.09%)

Options
Cloudflare put block on Cboe closes 6 month trade for 87% gain » 14:50
09/22/20
09/22
14:50
09/22/20
14:50
NET

Cloudflare

$39.40 /

+0.465 (+1.19%)

Cloudflare put block on…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NET Cloudflare
$39.40 /

+0.465 (+1.19%)

NET Cloudflare
$39.40 /

+0.465 (+1.19%)

14:38 Today JMP Securities
JMP Securities maintains Outperform on Cloudflare after positive commentary
08/04/20 RBC Capital
Cloudflare price target raised to $48 from $29 at RBC Capital
07/30/20 Oppenheimer
Cloudflare price target raised to $55 from $35 at Oppenheimer
07/30/20 Baird
Cloudflare price target raised to $45 from $30 at Baird
NET Cloudflare
$39.40 /

+0.465 (+1.19%)

NET Cloudflare
$39.40 /

+0.465 (+1.19%)

NET Cloudflare
$39.40 /

+0.465 (+1.19%)

NET Cloudflare
$39.40 /

+0.465 (+1.19%)

Options
Nike options imply 8.5% move in share price post-earnings » 14:49
09/22/20
09/22
14:49
09/22/20
14:49
NKE

Nike

$116.55 /

+3.24 (+2.86%)

Pre-earnings options…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NKE Nike
$116.55 /

+3.24 (+2.86%)

NKE Nike
$116.55 /

+3.24 (+2.86%)

07:09 Today Baird
Nike price target raised to $115 but limited upside seen, says Baird
09/18/20 Needham
Nike price target raised to $132 from $113 at Needham
09/18/20 Morgan Stanley
Nike price target raised to $142 from $121 at Morgan Stanley
09/18/20 Raymond James
Nike price target raised to $121 from $115 at Raymond James
NKE Nike
$116.55 /

+3.24 (+2.86%)

NKE Nike
$116.55 /

+3.24 (+2.86%)

NKE Nike
$116.55 /

+3.24 (+2.86%)

NKE Nike
$116.55 /

+3.24 (+2.86%)

Options
Atlassian call volume above normal and directionally bullish » 14:45
09/22/20
09/22
14:45
09/22/20
14:45
TEAM

Atlassian

$178.91 /

+1.51 (+0.85%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TEAM Atlassian
$178.91 /

+1.51 (+0.85%)

TEAM Atlassian
$178.91 /

+1.51 (+0.85%)

09/16/20
Fly Intel: Top five analyst initiations
09/16/20 Piper Sandler
Piper sees Atlassian as next $5B software business, starts at Overweight
09/15/20 Piper Sandler
Atlassian initiated with an Overweight at Piper Sandler
07/31/20 DA Davidson
Atlassian price target raised to $200 from $171 at DA Davidson
TEAM Atlassian
$178.91 /

+1.51 (+0.85%)

TEAM Atlassian
$178.91 /

+1.51 (+0.85%)

TEAM Atlassian
$178.91 /

+1.51 (+0.85%)

TEAM Atlassian
$178.91 /

+1.51 (+0.85%)

General news
Atlanta Federal Reserve Bank President Raphael Bostic Speech to be released at 15:00  14:45
09/22/20
09/22
14:45
09/22/20
14:45
 
Recommendations
JMP Securities maintains Outperform on Cloudflare after positive commentary » 14:38
09/22/20
09/22
14:38
09/22/20
14:38
NET

Cloudflare

$39.40 /

+0.465 (+1.19%)

JMP Securities analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NET Cloudflare
$39.40 /

+0.465 (+1.19%)

NET Cloudflare
$39.40 /

+0.465 (+1.19%)

08/04/20 RBC Capital
Cloudflare price target raised to $48 from $29 at RBC Capital
07/30/20 Oppenheimer
Cloudflare price target raised to $55 from $35 at Oppenheimer
07/30/20 Baird
Cloudflare price target raised to $45 from $30 at Baird
07/28/20 Jefferies
Cloudflare upgraded to Buy from Hold at Jefferies
NET Cloudflare
$39.40 /

+0.465 (+1.19%)

NET Cloudflare
$39.40 /

+0.465 (+1.19%)

NET Cloudflare
$39.40 /

+0.465 (+1.19%)

NET Cloudflare
$39.40 /

+0.465 (+1.19%)

Hot Stocks
Sorrento Therapeutics releases results of Phase 1B trial of Resiniferatoxin » 14:33
09/22/20
09/22
14:33
09/22/20
14:33
SRNE

Sorrento Therapeutics

$9.56 /

-0.2 (-2.05%)

Sorrento Therapeutics,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SRNE Sorrento Therapeutics
$9.56 /

-0.2 (-2.05%)

SRNE Sorrento Therapeutics
$9.56 /

-0.2 (-2.05%)

07/31/20 H.C. Wainwright
Sorrento Therapeutics price target raised to $30 from $24 at H.C. Wainwright
07/20/20 Dawson James
Sorrento antibody cocktail effort could move quickly, says Dawson James
05/26/20 Dawson James
Sorrento Therapeutics initiated with a Buy at Dawson James
10/07/19 JMP Securities
Sorrento Therapeutics initiated with an Outperform at JMP Securities
SRNE Sorrento Therapeutics
$9.56 /

-0.2 (-2.05%)

SRNE Sorrento Therapeutics
$9.56 /

-0.2 (-2.05%)

SRNE Sorrento Therapeutics
$9.56 /

-0.2 (-2.05%)

General news
Treasury Action: the bond market is little changed » 14:25
09/22/20
09/22
14:25
09/22/20
14:25

Treasury Action: the bond…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Conference/Events
Joint Economic Committee to hold a virtual hearing » 14:25
09/22/20
09/22
14:25
09/22/20
14:25

The Joint Economic…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

General news
California reports 784,324 COVID-19 cases, up 2,630 from prior day » 14:20
09/22/20
09/22
14:20
09/22/20
14:20
SPY

SPDR S&P 500 ETF Trust

$329.68 /

+2.67 (+0.82%)

, SPX

S&P 500

$0.00 /

+ (+0.00%)

Data from state's…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SPY SPDR S&P 500 ETF Trust
$329.68 /

+2.67 (+0.82%)

SPX S&P 500
$0.00 /

+ (+0.00%)

SPY SPDR S&P 500 ETF Trust
$329.68 /

+2.67 (+0.82%)

09/01/20
Fed's Brainard says monetary policy to pivot from stabilization to accommodation
08/17/20 Goldman Sachs
Goldman boosts end of 2020 S&P 500 target to 3,600 from 3,000
06/04/20 Keefe Bruyette
Mattis rebuke 'wake up call' for stock market, says Keefe Bruyette
03/11/20 Goldman Sachs
Goldman Sachs believes the S&P 500 bull market will soon end
SPX S&P 500
$0.00 /

+ (+0.00%)

09/01/20
Fed's Brainard says monetary policy to pivot from stabilization to accommodation
08/17/20 Goldman Sachs
Goldman boosts end of 2020 S&P 500 target to 3,600 from 3,000
06/04/20 Keefe Bruyette
Mattis rebuke 'wake up call' for stock market, says Keefe Bruyette
03/11/20 Goldman Sachs
Goldman Sachs believes the S&P 500 bull market will soon end
SPY SPDR S&P 500 ETF Trust
$329.68 /

+2.67 (+0.82%)

SPX S&P 500
$0.00 /

+ (+0.00%)

SPY SPDR S&P 500 ETF Trust
$329.68 /

+2.67 (+0.82%)

SPX S&P 500
$0.00 /

+ (+0.00%)

SPY SPDR S&P 500 ETF Trust
$329.68 /

+2.67 (+0.82%)

SPX S&P 500
$0.00 /

+ (+0.00%)

SPY SPDR S&P 500 ETF Trust
$329.68 /

+2.67 (+0.82%)

SPX S&P 500
$0.00 /

+ (+0.00%)

Technical Analysis
NASDAQ market internals summary » 14:17
09/22/20
09/22
14:17
09/22/20
14:17
$NSD

NASDAQ Market Internals

$0.00 /

+ (+0.00%)

Volume is above average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$NSD NASDAQ Market Internals
$0.00 /

+ (+0.00%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.